PCSK6
Basic information
Region (hg38): 15:101289784-101525202
Previous symbols: [ "PACE4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PCSK6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 5 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 4 | 10 | 4 |
Variants in PCSK6
This is a list of pathogenic ClinVar variants found in the PCSK6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-101291970-C-T | not specified | Uncertain significance (Aug 15, 2023) | ||
15-101292003-G-C | not specified | Uncertain significance (Jul 13, 2022) | ||
15-101293054-T-A | not specified | Uncertain significance (Dec 14, 2023) | ||
15-101293096-C-G | not specified | Uncertain significance (Apr 22, 2024) | ||
15-101305277-G-A | Likely benign (Sep 20, 2018) | |||
15-101313475-G-A | Likely benign (Dec 31, 2019) | |||
15-101318331-C-T | Benign (Dec 31, 2019) | |||
15-101322570-T-C | Likely benign (Dec 31, 2019) | |||
15-101370469-C-T | Likely benign (Oct 01, 2022) | |||
15-101370481-G-A | not specified | Likely benign (Jul 04, 2017) | ||
15-101370529-G-C | Benign (Dec 31, 2019) | |||
15-101382116-A-G | not specified | Benign (Mar 28, 2016) | ||
15-101384371-C-T | Benign (Dec 31, 2019) | |||
15-101393350-G-A | Likely benign (Nov 01, 2022) | |||
15-101398473-G-A | Likely benign (May 25, 2018) | |||
15-101432020-G-A | Likely benign (Nov 01, 2022) | |||
15-101489480-G-GGC | Benign (Jan 17, 2024) | |||
15-101489563-G-GGCGCCCCCC | Likely benign (Jan 01, 2023) | |||
15-101489572-C-A | Likely benign (Jun 01, 2022) | |||
15-101489663-G-A | not specified | Uncertain significance (Feb 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PCSK6 | protein_coding | protein_coding | ENST00000348070 | 23 | 224588 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.31e-13 | 0.999 | 125508 | 0 | 59 | 125567 | 0.000235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.41 | 438 | 530 | 0.827 | 0.0000328 | 6206 |
Missense in Polyphen | 128 | 216.64 | 0.59085 | 2300 | ||
Synonymous | 0.588 | 209 | 220 | 0.950 | 0.0000159 | 1831 |
Loss of Function | 3.14 | 29 | 53.9 | 0.538 | 0.00000299 | 608 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000764 | 0.000752 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000166 | 0.000163 |
Finnish | 0.0000490 | 0.0000462 |
European (Non-Finnish) | 0.000250 | 0.000246 |
Middle Eastern | 0.000166 | 0.000163 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Serine endoprotease that processes various proproteins by cleavage at paired basic amino acids, recognizing the RXXX[KR]R consensus motif. Likely functions in the constitutive secretory pathway, with unique restricted distribution in both neuroendocrine and non-neuroendocrine tissues.;
- Pathway
- Keratinization;Developmental Biology;Signal Transduction;Transport of small molecules;NGF processing;Expression and Processing of Neurotrophins;Signaling by NODAL;Signaling by NTRKs;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein assembly, remodeling, and clearance;Plasma lipoprotein remodeling;Signaling by Receptor Tyrosine Kinases;Formation of the cornified envelope
(Consensus)
Recessive Scores
- pRec
- 0.241
Haploinsufficiency Scores
- pHI
- 0.269
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.532
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.501
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pcsk6
- Phenotype
- skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); neoplasm; embryo phenotype; respiratory system phenotype; craniofacial phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- zygotic determination of anterior/posterior axis, embryo;determination of left/right symmetry;glycoprotein metabolic process;protein processing;peptide hormone processing;regulation of BMP signaling pathway;nerve growth factor production;secretion by cell;regulation of lipoprotein lipase activity;cornification
- Cellular component
- extracellular region;extracellular space;endoplasmic reticulum;Golgi lumen;plasma membrane;cell surface;membrane;collagen-containing extracellular matrix
- Molecular function
- endopeptidase activity;serine-type endopeptidase activity;protein binding;heparin binding;nerve growth factor binding